Kolexia
Stefani Laetitia Oncologie médicale
Stefani Laetitia
Oncologie médicale
Centre Hospitalier Annecy Genevois
Epagny Metz-Tessy, France
62 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs de l'ovaire Métastase tumorale Carcinome épithélial de l'ovaire Fatigue Neutropénie Lymphopénie Effets secondaires indésirables des médicaments Récidive tumorale locale

Collaborateurs

Voir plus
Leger Falandry Claire
Leger Falandry Claire
Hôpital Lyon Sud, Pierre-Bénite, France
Tredan Olivier
Tredan Olivier
Centre Léon-Bérard, Lyon, France
Bachelot Thomas
Bachelot Thomas
Centre Léon-Bérard, Lyon, France
Hardy-Bessard Anne-Claire
Hardy-Bessard Anne-Claire
Gie Groupement D'imagerie Armoricaine, Plérin, France

Industries

Voir plus
BMS
1 collaboration(s)
Dernière en 2020
Menarini
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study.
Cancer treatment and research communications   23 novembre 2023
QUALIOR: Study Evaluating the Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program, for Metastatic Cancer Patients Receiving Oral Targeted Therapy: The UNICANCER SdS 01 QUALIOR Study
Essai Clinique (Unicancer)   07 novembre 2023
InTTercePT: Treatment With Tucatinib in Addition to Pertuzumab and Trastuzumab in Patients With HER2-positive Metastatic Breast Cancer After Local Therapy of Isolated Brain Progression
Essai Clinique (Seagen)   21 septembre 2023
PADA-1: Randomized, Open Label, Multicentric Phase III Trial to Evaluate the Safety and Efficacy of Palbociclib in Combination With HT Driven by ctDNA ESR1 Mutation Monitoring in ER+, HER2-negative Metastatic Breast Cancer Patients
Essai Clinique (Pfizer)   21 septembre 2023
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer: Phase III Randomized Multicenter Trial Comparing Continued Maintenance Therapy With the Bevacizumab + Taxane Versus Bevacizumab + Substituting Exemestane in Patients With Metastatic Breast Cancer or Locally Advanced With Estrogen Receptor Positive and Having at Least a Stable Disease After 16 to 18 Weeks of Treatment With Bevacizumab + Taxane.
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
PROADAPT: Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' With Cancer, a Multicenter Pilot Study
Essai Clinique (Hospices Civils de Lyon)   24 août 2023
ADOPT-PRESTAGE: Randomized Controlled Trial on Acceptability, Diffusion and Impact on Treatment Adherence and Persistence of the PRESTAGE Program (Program for Education and Support for Oral Cancer Treatments in the Elderly) - Randomized Controlled Study Evaluating the Impact of the Program PRESTAGE
Essai Clinique (Hospices Civils de Lyon)   12 mai 2023
FASTRACS-RCT: Facilitate and Sustain Return to Work After Breast Cancer: Randomized Controlled Trial
Essai Clinique (Hospices Civils de Lyon)   24 février 2023
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
Breast cancer (Tokyo, Japan)   05 janvier 2023